Abstract
In this post-hoc analysis of data from a randomised clinical trial, we compared the effect of liraglutide to placebo on markers of insulin secretion in persons with type 2 diabetes treated with multiple daily insulin injections. Liraglutide increased insulin secretion, measured by C-peptide, by 19% after 24 weeks of treatment. Clinical trial registration: EudraCT 2012-001941-42.
Author supplied keywords
Cite
CITATION STYLE
Westman, K., Imberg, H., Wijkman, M. O., Hirsch, I. B., Tuomilehto, J., Dahlqvist, S., & Lind, M. (2022). Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections. Journal of Diabetes and Its Complications, 36(3). https://doi.org/10.1016/j.jdiacomp.2021.108110
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
